Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Debt / NOTE 3.000% 8/1
-
Market price (% of par)
-
103.6%
-
Total 13F principal
-
$157,102,000
-
Principal change
-
+$4,093,000
-
Total reported market value
-
$162,565,487
-
Number of holders
-
13
-
Value change
-
+$5,268,861
-
Number of buys
-
7
-
Number of sells
-
7
Institutional Holders of PTC THERAPEUTICS INC - NOTE 3.000% 8/1 as of Q1 2019
As of 31 Mar 2019,
PTC THERAPEUTICS INC - NOTE 3.000% 8/1 was held by
13 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$157,102,000
in principal (par value) of the bond.
The largest 10 bondholders included
Allianz Asset Management GmbH, WOLVERINE ASSET MANAGEMENT LLC, FARALLON CAPITAL MANAGEMENT LLC, DeepCurrents Investment Group LLC, CITADEL ADVISORS LLC, CAPSTONE INVESTMENT ADVISORS, LLC, D. E. Shaw & Co., Inc., UBS ASSET MANAGEMENT AMERICAS INC, CREDIT SUISSE AG/, and AMERIPRISE FINANCIAL INC.
This page lists
13
institutional bondholders reporting positions
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.